爵士製藥JAZZ
那斯達克 · USD
230.56
-5.61
(-2.38%)
收盤 06/13 03:59 (UTC+8)
盤後
234.72
+4.16
(+1.80%)
06/13 03:59 (UTC+8)
爵士製藥JAZZ
230.56
-5.61
(-2.38%)
財務數據
損益表
- 10.12
- 9.02
- 10.24
- 10.55
- 10.88
- 8.98
- 10.46
- 11.26
- 11.98
- 10.69
- 4.09
- -10.87
- 13.51
- 3.04
- 3.15
- -17.49
- 16.48
- 7.69
- 6.38
- -10.77
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | |
營業收入淨額 | 1,068,900 | 1,197,926 | 1,126,107 | 1,045,753 | 897,841 | 1,088,173 | 1,054,969 | 1,023,825 | 901,983 | 1,011,935 |
營業成本 | 134,100 | 153,528 | 128,880 | 116,288 | 104,620 | 128,713 | 111,611 | 109,902 | 95,487 | 107,243 |
營業毛利 | 934,800 | 1,044,398 | 997,227 | 929,465 | 793,221 | 959,460 | 943,358 | 913,923 | 806,496 | 904,692 |
營業費用 | 721,000 | 789,863 | 939,718 | 1,615,849 | 849,113 | 768,690 | 683,148 | - | 740,289 | 782,195 |
研發費用 | 196,000 | 213,909 | 198,203 | 189,924 | 180,652 | 240,500 | 199,919 | 220,734 | 222,847 | 216,608 |
推銷及管理費用 | 352,700 | 406,212 | 530,647 | 358,412 | 514,013 | 369,287 | 325,772 | 338,523 | 351,712 | 396,034 |
非經常性項目費用 | - | - | 42,500 | 905,362 | - | - | - | - | 10,000 | 18,000 |
其他營業費用 | 172,300 | 169,742 | 168,368 | 162,151 | 154,448 | 158,903 | 157,457 | 155,223 | 155,730 | 151,553 |
營業利益 | 336,600 | 254,535 | 57,509 | -686,384 | -55,892 | 190,770 | 260,210 | 199,443 | 66,207 | 122,497 |
其他收入及費用 | 125,300 | -658 | 102 | -1,812 | -213 | -6,295 | -701 | 507 | -1,693 | 9,353 |
利息費用 | 39,900 | 45,406 | 48,576 | 47,369 | 53,706 | 51,256 | 58,702 | 62,023 | 66,116 | 70,324 |
稅前純益 | 422,000 | 208,471 | 9,035 | -735,565 | -109,811 | 133,219 | 200,807 | 137,927 | -1,602 | 61,526 |
所得稅 | 6,100 | 4,963 | -242,424 | -17,182 | -17,812 | -57,912 | -14,533 | -30,653 | 11,669 | -33,089 |
稅後純益 | 293,100 | 203,451 | 251,412 | -718,511 | -92,541 | 191,115 | 215,055 | 168,568 | -14,618 | 94,154 |
基本每股稅後盈餘(元) | 4.73 | 3.33 | 4.14 | -11.74 | -1.52 | 3.16 | 3.50 | 2.68 | -0.23 | 1.50 |
稀釋每股稅後盈餘(元) | 4.43 | 3.34 | 4.10 | -11.76 | -1.52 | 3.02 | 3.28 | 2.58 | -0.23 | 1.43 |
基本平均股數(千股) | 61900.00 | 61058.00 | 60696.00 | 61194.00 | 60979.00 | 60538.00 | 61414.00 | 62882.00 | 62537.00 | 62578.00 |
稀釋平均股數(千股) | 66100.00 | 63433.00 | 61606.00 | 61194.00 | 60979.00 | 61503.00 | 63174.00 | 69625.00 | 62537.00 | 69673.00 |
還原基本每股稅後盈餘(元) | 4.73 | 3.33 | 4.14 | -11.74 | -1.52 | 3.16 | 3.50 | 2.68 | -0.23 | 1.50 |
還原稀釋每股稅後盈餘(元) | 4.43 | 3.34 | 4.10 | -11.76 | -1.52 | 3.02 | 3.28 | 2.58 | -0.23 | 1.43 |
還原基本平均股數(千股) | 61,900 | 61,058 | 60,696 | 61,194 | 60,979 | 60,538 | 61,414 | 62,882 | 62,537 | 62,578 |
還原稀釋平均股數(千股) | 66,100 | 63,433 | 61,606 | 61,194 | 60,979 | 61,503 | 63,174 | 69,625 | 62,537 | 69,673 |
EBITDA(千元) | 520,500 | 432,989 | 235,810 | -514,242 | 108,226 | 352,876 | 424,456 | 362,973 | 226,550 | 290,590 |